vs

Side-by-side financial comparison of ARK RESTAURANTS CORP (ARKR) and PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB). Click either name above to swap in a different company.

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. is the larger business by last-quarter revenue ($44.6M vs $40.7M, roughly 1.1× ARK RESTAURANTS CORP). ARK RESTAURANTS CORP runs the higher net margin — 2.2% vs -90.4%, a 92.6% gap on every dollar of revenue. On growth, PACIFIC BIOSCIENCES OF CALIFORNIA, INC. posted the faster year-over-year revenue change (13.8% vs -9.4%). ARK RESTAURANTS CORP produced more free cash flow last quarter ($-1.8M vs $-19.9M). Over the past eight quarters, PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s revenue compounded faster (7.3% CAGR vs -1.8%).

ARK Restaurants Corp operates a diversified portfolio of dining establishments across the United States, spanning casual dining, fast-casual, and upscale fine dining segments. Its offerings include American comfort food, BBQ, seafood, and Italian cuisine, serving local community patrons and tourist visitors across dozens of locations in multiple states.

Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.

ARKR vs PACB — Head-to-Head

Bigger by revenue
PACB
PACB
1.1× larger
PACB
$44.6M
$40.7M
ARKR
Growing faster (revenue YoY)
PACB
PACB
+23.2% gap
PACB
13.8%
-9.4%
ARKR
Higher net margin
ARKR
ARKR
92.6% more per $
ARKR
2.2%
-90.4%
PACB
More free cash flow
ARKR
ARKR
$18.1M more FCF
ARKR
$-1.8M
$-19.9M
PACB
Faster 2-yr revenue CAGR
PACB
PACB
Annualised
PACB
7.3%
-1.8%
ARKR

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ARKR
ARKR
PACB
PACB
Revenue
$40.7M
$44.6M
Net Profit
$896.0K
$-40.4M
Gross Margin
37.1%
Operating Margin
2.7%
-92.3%
Net Margin
2.2%
-90.4%
Revenue YoY
-9.4%
13.8%
Net Profit YoY
-71.7%
-1802.7%
EPS (diluted)
$0.25
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARKR
ARKR
PACB
PACB
Q4 25
$40.7M
$44.6M
Q3 25
$37.3M
$38.4M
Q2 25
$43.7M
$39.8M
Q1 25
$39.7M
$37.2M
Q4 24
$45.0M
$39.2M
Q3 24
$43.4M
$40.0M
Q2 24
$50.4M
$36.0M
Q1 24
$42.3M
$38.8M
Net Profit
ARKR
ARKR
PACB
PACB
Q4 25
$896.0K
$-40.4M
Q3 25
$-1.9M
$-38.0M
Q2 25
$-3.5M
$-41.9M
Q1 25
$-9.3M
$-426.1M
Q4 24
$3.2M
$2.4M
Q3 24
$-4.5M
$-60.7M
Q2 24
$640.0K
$-173.3M
Q1 24
$-1.4M
$-78.2M
Gross Margin
ARKR
ARKR
PACB
PACB
Q4 25
37.1%
Q3 25
41.4%
Q2 25
36.9%
Q1 25
-3.7%
Q4 24
25.6%
Q3 24
25.0%
Q2 24
16.5%
Q1 24
29.1%
Operating Margin
ARKR
ARKR
PACB
PACB
Q4 25
2.7%
-92.3%
Q3 25
-4.6%
-101.1%
Q2 25
-7.8%
-112.8%
Q1 25
-11.6%
-1154.5%
Q4 24
12.6%
-390.1%
Q3 24
-12.7%
-160.3%
Q2 24
1.6%
-488.3%
Q1 24
-2.8%
-209.6%
Net Margin
ARKR
ARKR
PACB
PACB
Q4 25
2.2%
-90.4%
Q3 25
-5.1%
-98.9%
Q2 25
-7.9%
-105.4%
Q1 25
-23.3%
-1146.8%
Q4 24
7.0%
6.0%
Q3 24
-10.3%
-151.9%
Q2 24
1.3%
-481.3%
Q1 24
-3.4%
-201.4%
EPS (diluted)
ARKR
ARKR
PACB
PACB
Q4 25
$0.25
$-0.11
Q3 25
$-0.53
$-0.13
Q2 25
$-0.96
$-0.14
Q1 25
$-2.57
$-1.44
Q4 24
$0.88
$-0.44
Q3 24
$-1.24
$-0.22
Q2 24
$0.18
$-0.64
Q1 24
$-0.40
$-0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARKR
ARKR
PACB
PACB
Cash + ST InvestmentsLiquidity on hand
$9.1M
$279.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$33.7M
$5.3M
Total Assets
$130.4M
$784.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARKR
ARKR
PACB
PACB
Q4 25
$9.1M
$279.5M
Q3 25
$11.3M
$298.7M
Q2 25
$12.3M
$314.7M
Q1 25
$11.1M
$343.1M
Q4 24
$13.1M
$389.9M
Q3 24
$10.3M
$471.1M
Q2 24
$11.5M
$509.8M
Q1 24
$10.4M
$561.9M
Stockholders' Equity
ARKR
ARKR
PACB
PACB
Q4 25
$33.7M
$5.3M
Q3 25
$32.7M
$36.1M
Q2 25
$34.7M
$61.5M
Q1 25
$38.1M
$91.6M
Q4 24
$47.3M
$506.6M
Q3 24
$44.1M
$453.1M
Q2 24
$48.9M
$492.7M
Q1 24
$49.7M
$649.0M
Total Assets
ARKR
ARKR
PACB
PACB
Q4 25
$130.4M
$784.1M
Q3 25
$133.5M
$803.2M
Q2 25
$136.3M
$825.5M
Q1 25
$141.9M
$860.8M
Q4 24
$154.6M
$1.3B
Q3 24
$156.0M
$1.5B
Q2 24
$166.5M
$1.5B
Q1 24
$169.6M
$1.7B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARKR
ARKR
PACB
PACB
Operating Cash FlowLast quarter
$-550.0K
$-19.1M
Free Cash FlowOCF − Capex
$-1.8M
$-19.9M
FCF MarginFCF / Revenue
-4.4%
-44.6%
Capex IntensityCapex / Revenue
3.1%
1.9%
Cash ConversionOCF / Net Profit
-0.61×
TTM Free Cash FlowTrailing 4 quarters
$-1.3M
$-114.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARKR
ARKR
PACB
PACB
Q4 25
$-550.0K
$-19.1M
Q3 25
$633.0K
$-18.7M
Q2 25
$1.9M
$-29.4M
Q1 25
$612.0K
$-44.1M
Q4 24
$-1.3M
$-30.6M
Q3 24
$728.0K
$-45.5M
Q2 24
$3.2M
$-54.3M
Q1 24
$208.0K
$-75.7M
Free Cash Flow
ARKR
ARKR
PACB
PACB
Q4 25
$-1.8M
$-19.9M
Q3 25
$-989.0K
$-18.8M
Q2 25
$1.2M
$-29.9M
Q1 25
$290.0K
$-45.4M
Q4 24
$-2.0M
$-32.3M
Q3 24
$-482.0K
$-46.3M
Q2 24
$2.5M
$-55.7M
Q1 24
$-148.0K
$-79.6M
FCF Margin
ARKR
ARKR
PACB
PACB
Q4 25
-4.4%
-44.6%
Q3 25
-2.6%
-48.9%
Q2 25
2.7%
-75.3%
Q1 25
0.7%
-122.3%
Q4 24
-4.4%
-82.3%
Q3 24
-1.1%
-115.7%
Q2 24
5.0%
-154.8%
Q1 24
-0.4%
-205.0%
Capex Intensity
ARKR
ARKR
PACB
PACB
Q4 25
3.1%
1.9%
Q3 25
4.3%
0.2%
Q2 25
1.5%
1.4%
Q1 25
0.8%
3.7%
Q4 24
1.4%
4.1%
Q3 24
2.8%
2.0%
Q2 24
1.2%
4.1%
Q1 24
0.8%
10.0%
Cash Conversion
ARKR
ARKR
PACB
PACB
Q4 25
-0.61×
Q3 25
Q2 25
Q1 25
Q4 24
-0.43×
-12.93×
Q3 24
Q2 24
4.94×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ARKR
ARKR

Segment breakdown not available.

PACB
PACB

Products$39.0M87%
Service And Other$5.7M13%

Related Comparisons